Dopamine as a therapeutic agent in stomach cancer
多巴胺作为胃癌的治疗剂
基本信息
- 批准号:9013455
- 负责人:
- 金额:$ 31.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-03-01 至 2018-02-28
- 项目状态:已结题
- 来源:
- 关键词:8-hydroxy-2&apos-deoxyguanosineAddressAdultAgonistAnimalsCancer EtiologyCellsCessation of lifeClinicalCyclic AMP-Dependent Protein KinasesCytoprotectionDNA DamageDiseaseDisease ProgressionDopamineEpithelial CellsExperimental DesignsGastric TissueGoalsGrowthHealthHelicobacter felisHumanIncidenceKnockout MiceKnowledgeLeadLesionMalignant NeoplasmsMeasuresMediatingMusOxidative StressPathway interactionsPatientsPlayPre-Clinical ModelPreventionProcessProductionReactive Oxygen SpeciesReceptor SignalingReportingResearchResearch DesignRoleSecond Primary CancersSignal PathwaySpecificityStagingStomachSystemTherapeutic AgentsTissuesTreatment EfficacyWild Type Mousecancer cellcancer typecarcinogenesiscombatdisease diagnosisdopamine D5 receptoreffective therapyefficacy testingin vivoindexingmalignant stomach neoplasmneutrophilnovelnovel therapeuticspreventpromoterreceptorreceptor functiontime intervaltreatment effecttumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Gastric cancer is one of the leading causes of cancer-related deaths in the world. Despite major research and clinical efforts, the results for th treatment of gastric cancer in general have been poor and thus newer and effective therapies are necessary to combat this disease. With reports indicating that substantial amount of DA is produced in normal stomach tissues and DA mediates cytoprotection of gastric epithelial cells by acting through its receptors present in these cells, we therefore postulated that this non-neuronal dopaminergic system in the stomach might also play an important role in gastric tumorigenesis. Thus Aim 1 will investigate the role of non-neuronal stomach dopaminergic system in gastric tumorigenesis, Aim 2 will elucidate the signaling pathway through which dopamine D5 receptors regulate reactive oxygen species in stomach and Aim 3 will determine the therapeutic efficacies of DA D5 receptor agonists in gastric tumorigenesis. The knowledge generated from this study will help to develop newer and effective therapies for this disease, which, as of yet, has no significant treatment.
描述(由申请人提供):胃癌是世界上癌症相关死亡的主要原因之一。尽管有重大的研究和临床努力,但胃癌的治疗结果总体上很差,因此需要更新和有效的治疗方法来对抗这种疾病。有报道表明正常胃组织中产生大量的DA,并且DA通过其存在于胃上皮细胞中的受体介导胃上皮细胞的细胞保护,因此我们推测胃中的这种非神经元多巴胺能系统也可能在胃肿瘤发生中起重要作用。因此,本研究的目的1是探讨非神经元型胃多巴胺能系统在胃癌发生中的作用,目的2是阐明多巴胺D5受体调节胃内活性氧的信号通路,目的3是确定多巴胺D5受体激动剂在胃癌发生中的治疗效果。从这项研究中产生的知识将有助于为这种疾病开发更新和有效的治疗方法,到目前为止,这种疾病还没有显著的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sujit Basu其他文献
Sujit Basu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sujit Basu', 18)}}的其他基金
IL-27 as a potential immunotherapeutic for cancer
IL-27 作为癌症的潜在免疫疗法
- 批准号:
10640105 - 财政年份:2019
- 资助金额:
$ 31.96万 - 项目类别:
CD200R signaling in tumor growth, immunity and immunotherapy
CD200R 信号在肿瘤生长、免疫和免疫治疗中的作用
- 批准号:
10441487 - 财政年份:2018
- 资助金额:
$ 31.96万 - 项目类别:
Dopamine as a therapeutic agent in stomach cancer
多巴胺作为胃癌的治疗剂
- 批准号:
9231439 - 财政年份:2013
- 资助金额:
$ 31.96万 - 项目类别:
Dopamine as a therapeutic agent in stomach cancer
多巴胺作为胃癌的治疗剂
- 批准号:
8616362 - 财政年份:2013
- 资助金额:
$ 31.96万 - 项目类别:
Dopamine as a therapeutic agent in stomach cancer
多巴胺作为胃癌的治疗剂
- 批准号:
8518948 - 财政年份:2013
- 资助金额:
$ 31.96万 - 项目类别:
Role of dopamine in the regulation of endothelial cell functions in diabetes
多巴胺在糖尿病内皮细胞功能调节中的作用
- 批准号:
8720762 - 财政年份:2012
- 资助金额:
$ 31.96万 - 项目类别:
Role of dopamine in the regulation of endothelial cell functions in diabetes
多巴胺在糖尿病内皮细胞功能调节中的作用
- 批准号:
8460332 - 财政年份:2012
- 资助金额:
$ 31.96万 - 项目类别:
Role of dopamine in the regulation of endothelial cell functions in diabetes
多巴胺在糖尿病内皮细胞功能调节中的作用
- 批准号:
8542843 - 财政年份:2012
- 资助金额:
$ 31.96万 - 项目类别:
相似海外基金
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
- 批准号:
10305569 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
- 批准号:
10488244 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10488242 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10488237 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10305565 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10305568 - 财政年份:2021
- 资助金额:
$ 31.96万 - 项目类别:
RUI: Chemical Investigations into the Bioactivity of the DNA Lesion 8-Oxo-2'-deoxyguanosine
RUI:DNA 损伤 8-Oxo-2-脱氧鸟苷生物活性的化学研究
- 批准号:
1903855 - 财政年份:2019
- 资助金额:
$ 31.96万 - 项目类别:
Standard Grant
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2017
- 资助金额:
$ 31.96万 - 项目类别:
Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2015
- 资助金额:
$ 31.96万 - 项目类别:
Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2014
- 资助金额:
$ 31.96万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




